These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9696215)

  • 21. A comparison of bromocriptine & cabergoline on fertility outcome of hyperprolactinemic infertile women undergoing intrauterine insemination.
    Motazedian S; Babakhani L; Fereshtehnejad SM; Mojthahedi K
    Indian J Med Res; 2010 May; 131():670-4. PubMed ID: 20516539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin levels in infertility and bromocriptine therapy in hyperprolactinaemia.
    Prathibha D; Govardhani M; Krishna PT
    J Indian Med Assoc; 1994 Dec; 92(12):397-9. PubMed ID: 7876578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocrine basis for recurrent pregnancy loss.
    Ke RW
    Obstet Gynecol Clin North Am; 2014 Mar; 41(1):103-12. PubMed ID: 24491986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperprolactinemia. Long-term effects of bromocriptine.
    Johnston DG; Prescott RW; Kendall-Taylor P; Hall K; Crombie AL; Hall R; McGregor A; Watson MJ; Cook DB
    Am J Med; 1983 Nov; 75(5):868-74. PubMed ID: 6638052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy of novel unidirectional buccoadhesive vs. vaginoadhesive bromocriptine mesylate discs for treating pathologic hyperprolactinemia.
    Darwish AM; El-Sayed AM; El-Harras SA; Khaled KA; Ismail MA
    Fertil Steril; 2008 Nov; 90(5):1864-8. PubMed ID: 18462734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
    Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent bromocriptine treatment for the induction of ovulation in hyperprolactinemic patients.
    Bennink HJ
    Fertil Steril; 1979 Mar; 31(3):267-72. PubMed ID: 571359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hachimijiogan treatment is effective in the management of infertile women with hyperprolactinemia or bromocriptine-resistant hyperprolactinemia.
    Usuki S; Usuki Y
    Am J Chin Med; 1989; 17(3-4):225-41. PubMed ID: 2633624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of bromocriptine therapy to control juvenile mammary hypertrophy.
    Arscott GD; Craig HR; Gabay L
    Br J Plast Surg; 2001 Dec; 54(8):720-3. PubMed ID: 11728119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of bromocriptine to suppress prolactin in majeptil-induced hyperprolactinemia.
    Yarkoni S; Spitz IM; Ben-David M; Polishuk WZ
    Acta Eur Fertil; 1978 Dec; 9(4):185-8. PubMed ID: 573042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
    Ono M; Miki N; Amano K; Kawamata T; Seki T; Makino R; Takano K; Izumi S; Okada Y; Hori T
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2672-9. PubMed ID: 20357175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A; Landi ML; Cappabianca P; Di Salle F; Rossi FW; Pivonello R; Di Somma C; Faggiano A; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of bromocriptine on antipsychotic drug-induced hyperprolactinemia: eight-week randomized, single-blind, placebo-controlled, multicenter study.
    Lee MS; Song HC; An H; Yang J; Ko YH; Jung IK; Joe SH
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):19-27. PubMed ID: 19968833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Correlation of prolactin-secreting-capacity to circadian profile of prolactin in euprolactinemic women with ovulatory disturbances].
    Mori H; Aisaka K; Matsuoka R; Kigawa T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Feb; 37(2):287-92. PubMed ID: 3919123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The influence of bromocriptine treatment on prolactin secretion in infertile women with suspicion of luteal phase insufficiency].
    Krzemiński A; Sikorski R; Woźniak S
    Ginekol Pol; 1998 Dec; 69(12):1141-5. PubMed ID: 10224791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
    Yuen BH
    Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of oligozoospermia with marginal hyperprolactinemia due to pituitary microadenoma].
    Kawano M; Yasumoto R; Tsujino T; Masuda C; Sakakura T; Nishisaka N; Kishimoto T
    Hinyokika Kiyo; 1996 Apr; 42(4):319-21. PubMed ID: 8693969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.